Pre-Summer Research Planning: Peptides for Metabolic Studies

The pre-summer period offers several advantages for launching metabolic peptide research:

Practical Advantages: - Research teams are typically at full capacity before summer holiday schedules - Supply chains are operating normally (summer can introduce shipping delays in some regions) - Environmental conditions are moderate (easier cold-chain management than peak summer) - Budget cycles in many institutions align with mid-year spending

Scientific Advantages: - Metabolic research benefits from controlling seasonal variables — starting in spring and running through summer provides consistent daylight and activity patterns - Body composition baselines established in spring are more stable than winter measurements (less holiday-season dietary confounding) - Longer daylight hours support compliance in protocols involving exercise components

ORYN's Peak Performance Campaign Alignment: ORYN's Peak Performance campaign (May 15 – June 30, 2026) was designed to align with this optimal research window, offering discounted bundles on the key metabolic peptides: tirzepatide, NAD+, CJC-1295, and ipamorelin.

This guide helps researchers plan effectively to maximise both research outcomes and campaign savings.

Before selecting compounds, clarify your research objectives:

Weight/Fat Management Research: - Primary compound: Tirzepatide (strongest evidence for fat mass reduction) - Supporting compounds: CJC-1295 + ipamorelin (lean mass preservation), NAD+ (metabolic efficiency) - Key endpoints: Body weight, DXA body composition, waist circumference, metabolic panels - Minimum duration: 12-16 weeks (time to reach maintenance dose + observe effects)

GH Biology / Recovery Research: - Primary compounds: CJC-1295 + ipamorelin stack - Supporting compound: BPC-157 (tissue repair), NAD+ (mitochondrial function) - Key endpoints: IGF-1 levels, body composition, sleep quality, recovery markers - Minimum duration: 8-12 weeks

NAD+ / Ageing / Mitochondrial Research: - Primary compound: NAD+ (Pen or NovaDose) - Supporting compounds: Glutathione (antioxidant support) - Key endpoints: NAD+ blood levels, sirtuin activity markers, mitochondrial function, metabolic panels - Minimum duration: 8-12 weeks (longer for ageing endpoints)

Multi-Pathway Metabolic Research: - Compounds: Tirzepatide + CJC-1295/ipamorelin + NAD+ - Key endpoints: Comprehensive metabolic panel, body composition, functional outcomes - Minimum duration: 16-24 weeks - Complexity: Highest — requires careful protocol design to attribute effects to individual compounds

Match your research design to the appropriate ORYN products:

For Tirzepatide Research: - Tirzepatide Pen (€169): Standard pen with adjustable dosing — ideal for dose-escalation protocols - MediT Pen (€249): 40mg prefilled weekly pen — ideal for established maintenance dose research - Metabolic Transformation Stack: Both pens bundled at 12% off during Peak Performance

For GH Secretagogue Research: - CJC-1295 Pen (€129): 30-day supply, precision dosing - Ipamorelin Pen (€129): 30-day supply, precision dosing - Growth Hormone Stack: Both pens bundled at 15% off during Peak Performance

For NAD+ Research: - NAD+ Pen (€189): Fixed daily dose — best for standardised protocols - NovaDose NAD+ (€299): Adjustable daily microdosing — best for dose-response or titration studies - NAD+ Complete Stack: Both systems bundled at 12% off during Peak Performance

For Comprehensive Protocols: - Total Wellness Stack: BPC-157 + NAD+ + Glutathione at 15% off - Combine with any other stack using code PEAK26 for tiered discounts: 10% on 2 products, 15% on 3+

Delivery System Decision: - If your protocol needs fixed, repeatable dosing → standard pen - If you need dose flexibility or titration → NovaDose - If your protocol specifies weekly tirzepatide at a fixed dose → MediT Pen

A well-designed timeline ensures you capture meaningful data within your research window:

Example 16-Week Tirzepatide + GH Protocol:

| Week | Tirzepatide | CJC-1295 + Ipamorelin | Assessments | |------|------------|----------------------|-------------| | 0 | — | — | Baseline: DXA, blood panel, vitals | | 1-4 | 2.5 mg/wk | Full dose daily | Week 4: tolerability check, blood panel | | 5-8 | 5 mg/wk | Full dose daily | Week 8: DXA, blood panel, midpoint review | | 9-12 | 10 mg/wk | Full dose daily | Week 12: DXA, blood panel, efficacy review | | 13-16 | 15 mg/wk (if tolerated) | Full dose daily | Week 16: Final DXA, comprehensive panel |

Example 12-Week NAD+ Dose-Response Protocol:

| Week | NovaDose NAD+ | Assessments | |------|--------------|-------------| | 0 | — | Baseline: NAD+ blood level, metabolic panel | | 1-3 | Low dose | Week 3: NAD+ level, tolerability | | 4-6 | Medium dose | Week 6: NAD+ level, mitochondrial markers | | 7-9 | High dose | Week 9: NAD+ level, sirtuin activity | | 10-12 | Target dose | Week 12: Comprehensive final panel |

Timeline Planning Tips: - Order compounds 1-2 weeks before protocol start (account for shipping) - Schedule baseline assessments before first dose - Build in 1-week buffer at the end for any missed assessments - If launching in late May, a 16-week protocol extends through September — within normal research team availability

Reliable compound supply is critical for uninterrupted protocols:

ORYN Ordering Logistics: - UK delivery: Next-day (Mon-Fri) - EU delivery: 2-5 business days - All shipments include cold-chain packaging (insulated + ice packs) - Certificate of Analysis (COA) included with every order - Batch-specific documentation for research records

Quantity Planning: - Each standard pen = 30-day supply - For a 16-week protocol: Order 4 pens per compound - For stacks: 4× CJC-1295 + 4× Ipamorelin = 8 pens total - NovaDose cartridges: Duration depends on dose selected

Budget Optimisation (Peak Performance Campaign): - Campaign dates: May 15 – June 30, 2026 - Metabolic Transformation Stack: Tirzepatide Pen + MediT Pen (12% off) - Growth Hormone Stack: CJC-1295 + Ipamorelin (15% off) - NAD+ Complete Stack: NAD+ Pen + NovaDose NAD+ (12% off) - Total Wellness Stack: BPC-157 + NAD+ + Glutathione (15% off) - Code PEAK26: 10% off 2 products, 15% off 3+ products - Free priority delivery on orders >€400

Supply Continuity: - For multi-month protocols, consider ordering the full protocol supply during the campaign period (May 15 – June 30) to lock in savings - ORYN pen shelf life is 24 months at 2-8°C — ordering ahead does not risk expiration - Set up a reorder reminder at 75% protocol completion if ordering in phases

Proper documentation strengthens research validity and reproducibility:

Essential Records: - Protocol document: Compound(s), dose(s), schedule, endpoints, inclusion/exclusion criteria - Certificates of Analysis: ORYN provides batch-specific COAs with HPLC purity data and mass spectrometry confirmation - Administration log: Date, time, dose, lot number, injection site for each administration - Storage log: Refrigerator temperature records (min/max), any excursion events - Assessment data: Standardised forms for each endpoint at each time point

Quality Considerations: - Verify peptide purity (ORYN: >99% HPLC verified) - Confirm GMP manufacturing (ORYN: South Korea, GMP-certified) - Check sterilisation method (ORYN: 0.22μm filtration + gamma ray) - Ensure proper cold-chain from delivery to storage to use

Reporting Standards: - Record compound source, lot numbers, and purity in all publications - Document delivery system used (pen type, dose mechanism) - Report any deviations from planned protocol (missed doses, dose adjustments) - Include storage conditions and compound stability data

Starting your summer research with proper planning and documentation ensures that your results are not only scientifically meaningful but also reproducible and publishable.

Visit /peak-performance for campaign bundles and pricing. All ORYN products are sold for research purposes only.